PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 59 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $35,000 | -53.9% | 201,600 | +59.2% | 0.00% | -50.0% |
Q2 2022 | $76,000 | -79.9% | 126,600 | -55.8% | 0.00% | -71.4% |
Q1 2022 | $378,000 | -49.5% | 286,600 | 0.0% | 0.01% | -50.0% |
Q4 2021 | $748,000 | +17.1% | 286,600 | +39.4% | 0.01% | +16.7% |
Q3 2021 | $639,000 | +93.6% | 205,600 | +132.1% | 0.01% | +100.0% |
Q2 2021 | $330,000 | -15.4% | 88,600 | -21.3% | 0.01% | -14.3% |
Q1 2021 | $390,000 | -9.1% | 112,600 | -11.8% | 0.01% | -22.2% |
Q4 2020 | $429,000 | -20.0% | 127,600 | -16.4% | 0.01% | -25.0% |
Q3 2020 | $536,000 | -23.6% | 152,600 | 0.0% | 0.01% | -14.3% |
Q2 2020 | $702,000 | +15.7% | 152,600 | -16.8% | 0.01% | 0.0% |
Q1 2020 | $607,000 | -43.1% | 183,500 | +5.2% | 0.01% | 0.0% |
Q4 2019 | $1,066,000 | – | 174,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Johnson & Johnson Innovation - JJDC, Inc. | 1,607,044 | $5,400,000 | 0.70% |
NEA Management Company, LLC | 6,643,704 | $22,323,000 | 0.59% |
DAFNA Capital Management LLC | 320,542 | $1,077,000 | 0.32% |
Platform Technology Partners | 141,025 | $474,000 | 0.23% |
Parkman Healthcare Partners LLC | 110,547 | $371,000 | 0.10% |
Rock Springs Capital Management LP | 1,314,374 | $4,416,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 140,341 | $472,000 | 0.08% |
SABBY MANAGEMENT, LLC | 65,000 | $218,000 | 0.04% |
Virtu Financial LLC | 28,821 | $97,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 127,600 | $429,000 | 0.01% |